Why Most Cancer Patients on Active Treatment Should Get 4 Doses of the COVID-19 Vaccine
As you may have heard, the CDC now recommends an additional dose of the COVID-19 vaccine for people who are immunocompromised.
Related Articles
10 Trials and Growing: A Progress Update on the Thoracic Surgical
The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the American Association for Thoracic Surgery and the Fiona & Stanley Druckenmiller Center for Lung Cancer…
Comedy vs Cancer
Join us for a night of fun at MSK’s annual Comedy vs. Cancer event and help us outsmart blood cancer.
Remote Monitoring and Data Collection for Decentralized Clinical Trials
This survey study assesses the current state of decentralized trial technology adoption and highlights industry aspirations and directions for use to enable more patient-centric trials.
Jeffrey Drebin, MD, PhD, Named President-Elect of the American
An internationally recognized surgeon-scientist, Dr. Drebin has been named 2024 President-Elect of the American Surgical Association.
AACR 2024 Research Highlights From MSK
MSK investigators presented new research on a range of important topics at the 2024 Annual Meeting of the American Association for Cancer Research.
Myths About PSA Tests and Prostate Cancer Screening
PSA testing is an important part of screening for prostate cancer, when it’s used the right way. Learn the truth dispelling seven myths about the…
AACR: How Cellular Plasticity Drives Cancer Metastasis
In a plenary presentation at the 2024 American Association for Cancer Research (AACR) Annual Meeting, Dr. Dana Pe’er highlighted three recent research collaborations between her…
AACR: How Cellular Plasticity Drives Cancer Metastasis
In a plenary presentation at the 2024 American Association for Cancer Research (AACR) Annual Meeting, Dr. Dana Pe’er highlighted three recent research collaborations between her…
New Phase 1 Data from Memorial Sloan Kettering Cancer Center Shows an
New data presented today by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based…
Investigational mRNA Vaccine Induced Persistent Immune Response in
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.